Last month, two clinicians were part of a team that introduced a new chemotherapy technique at American Family Children’s Hospital to treat a patient with retinoblastoma, the most common type of eye cancer in children.

Dr. Margo Hoover-Regan, pediatric oncologist and clinical director of the Pediatric Hematology and Oncology Program, UW Health Kids, and associate professor, University of Wisconsin School of Medicine and Public Health, and Dr. Sudarshawn Damodharan, pediatric hematology/oncology fellow, UW Health, employed intra-arterial chemotherapy (IAC) to deliver anti-tumor drugs directly to the tumor bed in the retina.

“In the past, retinoblastoma treatments have included enucleation, or removal of the eye, radiation, and systemic chemotherapy,” Damodharan said. “Intra-arterial chemotherapy is superior to those methods in some cases.”

Click here to read the full article.